- Home
- VRDN vs APOG Comparison
VRDN vs APOG Comparison
Compare VRDN & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- APOG
- Stock Information
- Founded
- VRDN 2006
- APOG 1949
- Country
- VRDN United States
- APOG United States
- Employees
- VRDN N/A
- APOG N/A
- Industry
- VRDN Medical Specialities
- APOG Auto Parts:O.E.M.
- Sector
- VRDN Health Care
- APOG Consumer Discretionary
- Exchange
- VRDN Nasdaq
- APOG Nasdaq
- Market Cap
- VRDN 1.5B
- APOG 1.8B
- IPO Year
- VRDN N/A
- APOG N/A
- Fundamental
- Price
- VRDN $20.14
- APOG $82.03
- Analyst Decision
- VRDN Strong Buy
- APOG Hold
- Analyst Count
- VRDN 10
- APOG 1
- Target Price
- VRDN $37.25
- APOG $75.00
- AVG Volume (30 Days)
- VRDN 1.1M
- APOG 141.8K
- Earning Date
- VRDN 11-12-2024
- APOG 12-19-2024
- Dividend Yield
- VRDN N/A
- APOG 1.22%
- EPS Growth
- VRDN N/A
- APOG 4.28
- EPS
- VRDN N/A
- APOG 4.74
- Revenue
- VRDN $302,000.00
- APOG $1,375,510,000.00
- Revenue This Year
- VRDN N/A
- APOG N/A
- Revenue Next Year
- VRDN N/A
- APOG $4.80
- P/E Ratio
- VRDN N/A
- APOG $17.31
- Revenue Growth
- VRDN N/A
- APOG N/A
- 52 Week Low
- VRDN $11.40
- APOG $44.46
- 52 Week High
- VRDN $27.20
- APOG $87.93
- Technical
- Relative Strength Index (RSI)
- VRDN 36.38
- APOG 57.36
- Support Level
- VRDN $22.40
- APOG $74.72
- Resistance Level
- VRDN $27.20
- APOG $87.93
- Average True Range (ATR)
- VRDN 1.36
- APOG 2.04
- MACD
- VRDN -0.41
- APOG 0.13
- Stochastic Oscillator
- VRDN 6.37
- APOG 55.34
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. Its segments are Architectural Framing Systems; Architectural Glass; Architectural Services and Large-Scale Optical Technologies (LSO). It generates maximum revenue from the Architectural Framing Systems segment. The Architectural Framing Systems segment designs, engineers, fabricates, and finishes the aluminum frames used in customized aluminum and glass windows, curtainwall, storefront, and entrance systems comprising the outside skin and entrances of commercial, institutional, and others. Geographically, it derives a majority of its revenue from the United States.